Gillian O'Hurley et al.
Histopathology, 64(5), 660-670 (2013-10-22)
Triple-negative breast cancer (TNBC) is responsible for a disproportionate number of breast cancer (BC) deaths, owing to its intrinsic aggressiveness and a lack of treatment options, especially targeted therapies. Thus, there is an urgent need for the development of better...
AKT3 regulates ErbB2, ErbB3 and estrogen receptor a expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Cellular Signalling, 26(5), 1021-1029 (2014)
Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.
Proceedings of the National Academy of Sciences of the USA, 112(11), 3421-3426 (2015)
Targeting Akt3 signaling in triple-negative breast cancer.
Cancer Research, 74(3), 964-973 (2014)
Phenotypes of AKT3 deletion: a case report and literature review.
American Journal of Medical Genetics. Part A, 167A(1), 174-179 (2015)